Radicura Pharmaceuticals Private Limited, a active private limited company, was established on 02 May 1974 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1974PTC007245. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹1.38 Cr.
It upholds a compliant status. Its leadership includes Rajiv Jain (Director), Sanjeev Jain (Additional Director). Past directors included Pradip Jain. It holds ₹5.20 Cr open charges and ₹37.21 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-289, 1St Floor & Basement, Okhla Industrial Area,, Phase-1, New Delhi, Delhi, 110020.
U74899DL1974PTC007245
007245
02 May 1974
₹8.00 Cr
₹1.38 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Radicura Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Jain | Director | 25 Feb 1998 | Current |
| Sanjeev Jain | Additional Director | 26 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Radicura Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 36.5% increase. The company also saw a substantial improvement in profitability, with a 5048.12% increase in profit. The company's net worth Soared by an impressive increase of 127.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Radicura Pharmaceuticals had a public holding of 51.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹52,040,000.00
₹372,090,300.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2023 | Others | ₹5.00 Cr | Open |
| 27 Apr 2019 | Others | ₹0.76 M | Open |
| 27 Apr 2019 | Others | ₹1.20 M | Open |
| 06 Aug 1981 | Bank Of Madura Ltd. | ₹0.09 M | Open |
| 13 Dec 2023 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Radicura Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Radicura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicura Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Radicura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Radicura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Sanjeev Jain was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2025 & has been associated with this company since 9 months 3 days . was documented.
Progress on A charge registered on 13 Dec 2023 via Charge ID 100829982 with Others was fully satisfied on 16 Aug 2024. was documented.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100830029 was registered on 13 Dec 2023. was completed.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100829982 was registered on 13 Dec 2023. was completed.
The CIN of Radicura Pharmaceuticals Private Limited is U74899DL1974PTC007245.
Radicura Pharmaceuticals Private Limited is headquartered at B-289, 1St Floor & Basement, Okhla Industrial Area,, Phase-1, New Delhi, Delhi, 110020.
Radicura Pharmaceuticals Private Limited was incorporated on 02 May 1974.
The current directors of Radicura Pharmaceuticals Private Limited are
The primary industry of Radicura Pharmaceuticals Private Limited is Manufacturing.
Radicura Pharmaceuticals Private Limited is unlisted.
The authorized capital of Radicura Pharmaceuticals Private Limited is ₹8.00 Cr, and the paid-up capital is ₹1.38 Cr.
The compliance status of Radicura Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX